Mohammad Mazidi

463 total citations
38 papers, 377 citations indexed

About

Mohammad Mazidi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mohammad Mazidi has authored 38 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mohammad Mazidi's work include Radiopharmaceutical Chemistry and Applications (30 papers), Peptidase Inhibition and Analysis (7 papers) and Medical Imaging and Pathology Studies (7 papers). Mohammad Mazidi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (30 papers), Peptidase Inhibition and Analysis (7 papers) and Medical Imaging and Pathology Studies (7 papers). Mohammad Mazidi collaborates with scholars based in Iran, Germany and Belgium. Mohammad Mazidi's co-authors include Amir Reza Jalilian, Mohammad Shafiei, Reza Najafi, Reza Mosayebi Behbahani, Ali Fazeli, Ali Bahrami‐Samani, Parham Geramifar, Hassan Yousefnia, Mohammad Ghannadi‐Maragheh and Davood Beiki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Catalysis B: Environmental and Nuclear Medicine and Biology.

In The Last Decade

Mohammad Mazidi

37 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Mazidi Iran 10 222 104 69 57 54 38 377
Makbule Aşıkoğlu Türkiye 11 114 0.5× 73 0.7× 52 0.8× 60 1.1× 15 0.3× 31 298
Derya İlem‐Özdemir Türkiye 13 171 0.8× 104 1.0× 80 1.2× 94 1.6× 52 1.0× 55 580
M. T. Ercan Türkiye 12 104 0.5× 34 0.3× 92 1.3× 48 0.8× 12 0.2× 33 457
Meliha Ekinci Türkiye 11 110 0.5× 65 0.6× 19 0.3× 62 1.1× 29 0.5× 35 357
Edward Helal‐Neto Brazil 16 55 0.2× 49 0.5× 51 0.7× 46 0.8× 122 2.3× 24 480
Sun-Ju Choi South Korea 11 103 0.5× 32 0.3× 11 0.2× 26 0.5× 43 0.8× 24 322
Ahmed Mohsen Italy 13 118 0.5× 140 1.3× 31 0.4× 54 0.9× 24 0.4× 34 402
Samantha M. Fix United States 9 69 0.3× 49 0.5× 37 0.5× 37 0.6× 107 2.0× 15 489
Linda J. Chan Australia 12 40 0.2× 66 0.6× 22 0.3× 47 0.8× 14 0.3× 17 477
Huanhuan Liu Netherlands 11 82 0.4× 20 0.2× 39 0.6× 41 0.7× 71 1.3× 15 348

Countries citing papers authored by Mohammad Mazidi

Since Specialization
Citations

This map shows the geographic impact of Mohammad Mazidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Mazidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Mazidi more than expected).

Fields of papers citing papers by Mohammad Mazidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Mazidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Mazidi. The network helps show where Mohammad Mazidi may publish in the future.

Co-authorship network of co-authors of Mohammad Mazidi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Mazidi. A scholar is included among the top collaborators of Mohammad Mazidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Mazidi. Mohammad Mazidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jalilian, Amir Reza, et al.. (2016). Optimized preparation and evaluation of 99mTc-Streptomycin. 24(1). 46–50. 2 indexed citations
2.
Mazidi, Mohammad, Hassan Sadrnia, & Mehdi Khojastehpour. (2016). Evaluation of orange mechanical damage during packaging by study of changes in firmness.. International Food Research Journal. 23(2). 899–903. 6 indexed citations
3.
Yousefnia, Hassan, Ahmad Bitarafan‐Rajabi, Ali Bahrami‐Samani, et al.. (2016). Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma. 24(1). 59–64. 2 indexed citations
4.
Mirzaei, Alireza, et al.. (2015). Optimized production and quality control of 68Ga-EDTMP for small clinical trials. Annals of Nuclear Medicine. 29(6). 506–511. 16 indexed citations
5.
Yousefnia, Hassan, Amir Reza Jalilian, F. Abbasi Davani, et al.. (2014). Preparation and quality control of 177Lu-chitosan for radiosynovectomy. 22(1). 1–6. 3 indexed citations
6.
Moghaddam, B., et al.. (2013). Radiosynthesis of 191Os-2-acetylpyridine thiosemicarbazone complex, as an in vivo therapeutic radionuclide generator. 21(2). 53–59. 3 indexed citations
7.
Erfani, Mostafa, et al.. (2013). Preparation and Biological Evaluation of [ 99m Tc/EDDA/Tricine/HYNIC 0 , BzThi 3 ]-Octreotide for Somatostatin Receptor-Positive Tumor Imaging. Cancer Biotherapy and Radiopharmaceuticals. 28(3). 240–247. 7 indexed citations
8.
Salouti, Mojtaba, et al.. (2012). Radiolabeling of Ceftriaxone with 99mTc as a Targeting Radiopharmaceutical for Staphylococcus Aureus Detection in Mouse Model. SHILAP Revista de lepidopterología. 11 indexed citations
9.
Moghaddam, B., et al.. (2012). Preparation and quality control of scandium-46 bleomycin as a possible therapeutic agent. 20(1). 19–24. 8 indexed citations
10.
Jalilian, Amir Reza, et al.. (2011). Production of Holmium-166 DOTMP: A promising agent for bone marrow ablation in hematologic malignancies. 19(135). 12–20. 8 indexed citations
11.
Jalilian, Amir Reza, et al.. (2011). Development of 166Ho-phytate Complex for Radiosynovectomy. Nuclear Medicine and Molecular Imaging. 45(2). 87–92. 2 indexed citations
12.
Jalilian, Amir Reza, et al.. (2010). Development of Sm-153 chitosan for radiosynovectomy. 18(1). 22–31. 7 indexed citations
13.
Jalilian, Amir Reza, et al.. (2010). Production and quality control of 166Ho-Chitosan for therapeutic applications. 18(2). 1–8. 4 indexed citations
14.
Daha, Fariba Johari, et al.. (2010). Production of 177Lu and formulation of Ethylene diamine tetramethylene phosphonate (EDTMP) kits as a bone-seeking radiopharmaceutical. Iranian Journal of radiation research. 7(4). 229–234. 9 indexed citations
15.
Najafi, Rezvan, et al.. (2009). Three different procedures in labeling of Ubiquicidin with technetium 99m: a comparative study. Iranian Journal of radiation research. 7(2). 97–104. 6 indexed citations
16.
Shafiei, Mohammad, et al.. (2009). Synthesis and evaluation of a new radiolabeled bombesin analogue for diagnosis of GRP receptor expressing tumors. 17(131). 18–26. 6 indexed citations
17.
Najafi, Reza, et al.. (2009). Clinical evaluation of antimicrobial peptide [99mTc/Tricine/HYNIC0]ubiquicidin 29–41 as a human-specific infection imaging agent. Nuclear Medicine and Biology. 36(2). 199–205. 51 indexed citations
18.
Najafi, Reza, et al.. (2008). New peptide based freeze-dried kit [99mTc-HYNIC]-UBI 29-41 as a human specific infection imaging agent. 16(1). 25–30. 7 indexed citations
19.
Mazidi, Mohammad, et al.. (2008). Synthesis, labeling and quality control of a new Neuropeptide Y analogue for diagnosis of breast tumors. 16(129). 20–24. 1 indexed citations
20.
Mazidi, Mohammad, et al.. (2006). THE AMOUNT OF KNOWLEDGE IN IRANIAN FEMALE ADOLESCENTS STUDENT ABOUT OSTEOPOROSIS AND ITS RISK FACTORS. Journal of hayat. 12(3). 43–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026